Track topics on Twitter Track topics that are important to you
1000 Marina BoulevardSuite 200
United States of America
Phone: (650) 624-1000
Fax: (650) 624-1001
A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults
To evaluate the safety and immunogenicity of SF-2 rgp120 vaccine in MF59 versus MN rgp120 vaccine in alum in volunteers who are seronegative for HIV-1. AS PER AMENDMENT 07/02/97: To determ...
VaxGen were formed to continue development of AIDSVAX in partnership with Genentech. In connection with our formation, Genentech licensed to us the technology necessary for completing development and ...
VaxGen Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease. Founded in 1...
We have published hundreds of VaxGen Inc. news stories on BioPortfolio along with dozens of VaxGen Inc. Clinical Trials and PubMed Articles about VaxGen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of VaxGen Inc. Companies in our database. You can also find out about relevant VaxGen Inc. Drugs and Medications on this site too.
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...